Bredberg E, Lennernäs H, Paalzow L
Department of Biopharmaceutics and Pharmacokinetics, University of Uppsala, Sweden.
Pharm Res. 1994 Apr;11(4):549-55. doi: 10.1023/a:1018970617104.
This study examined the pharmacokinetics of levodopa and carbidopa in the rat after different modes of administration. The drugs were given simultaneously by the intravenous, intraarterial, oral, duodenal, and intraperitoneal routes, as single doses. The ratio of levodopa to carbidopa given was always 4:1. Two iv doses (5 and 15 mg/kg of levodopa) were given to test for nonlinearity. Three ip doses of levodopa were given (5, 7.5, and 15 mg/kg), and the 15 mg/kg dose was given in three volumes (2, 4, and 20 mL/kg). One oral dose and two intraduodenal doses of 15 mg/kg were given. The drugs were dissolved in saline in one of the intraduodenal doses and suspended in 1.8% methylcellulose in the other. The elimination of levodopa was nonlinear. There was a comparatively high degree of interindividual variability in absorption with the oral route, but this was substantially reduced when levodopa was given intraduodenally. There was also much less variability with the intraperitoneal route compared to the oral, and the degree of absorption was generally high. There was a significantly higher extent and slower rate of absorption when levodopa was administered ip in a large volume of vehicle. These results suggest that the oral route may not be the optimal method of delivering levodopa to patients who have a fluctuating response and that a continuous delivery system via the intraperitoneal or intraduodenal routes might be a better alternative.
本研究考察了左旋多巴和卡比多巴在大鼠体内不同给药方式后的药代动力学。药物以单剂量通过静脉内、动脉内、口服、十二指肠内和腹腔内途径同时给药。左旋多巴与卡比多巴的给药比例始终为4:1。给予两个静脉内剂量(左旋多巴5和15mg/kg)以测试非线性。给予三个腹腔内剂量的左旋多巴(5、7.5和15mg/kg),15mg/kg剂量以三种体积(2、4和20mL/kg)给予。给予一个口服剂量和两个十二指肠内剂量的15mg/kg。在其中一个十二指肠内剂量中,药物溶解于盐水中,在另一个剂量中悬浮于1.8%甲基纤维素中。左旋多巴的消除是非线性的。口服途径吸收时个体间差异程度较高,但当左旋多巴经十二指肠给药时,这种差异显著降低。与口服途径相比,腹腔内途径的变异性也小得多,且吸收程度一般较高。当以大量溶媒腹腔内给予左旋多巴时,吸收程度显著更高且吸收速率更慢。这些结果表明,对于反应波动的患者,口服途径可能不是递送左旋多巴的最佳方法,通过腹腔内或十二指肠内途径的持续递送系统可能是更好的选择。